The risks and benefits of radiotherapy with massive endoprosthetic replacement

J Bone Joint Surg Br. 2007 Oct;89(10):1352-5. doi: 10.1302/0301-620X.89B10.19233.

Abstract

Between 1966 and 2001, 1254 patients underwent excision of a bone tumour with endoprosthetic replacement. All patients who had radiotherapy were identified. Their clinical details were retrieved from their records. A total of 63 patients (5%) had received adjunctive radiotherapy, 29 pre-operatively and 34 post-operatively. The mean post-operative Musculoskeletal Tumor Society scores of irradiated patients were significantly lower (log-rank test, p = 0.009). The infection rate in the group who had not been irradiated was 9.8% (117 of 1191), compared with 20.7% (6 of 29) in those who had pre-operative radiotherapy and 35.3% (12 of 34) in those who radiotherapy post-operatively. The infection-free survival rate at ten years was 85.5% for patients without radiotherapy, 74.1% for those who had pre-operative radiotherapy and 44.8% for those who had post-operative radiotherapy (log-rank test, p < 0.001). The ten-year limb salvage rate was 89% for those who did not have radiotherapy and 76% for those who did (log-rank test, p = 0.02). Radiotherapy increased the risk of revision (log-rank test, p = 0.015). A total of ten amputations were necessary to control infection, of which nine were successful. Radiotherapy may be necessary for the treatment of a bone sarcoma but increases the risk of deep infection for which amputation may be the only solution.

Publication types

  • Comparative Study

MeSH terms

  • Amputation, Surgical / statistics & numerical data
  • Bone Neoplasms / radiotherapy*
  • Bone Neoplasms / surgery
  • Female
  • Humans
  • Male
  • Neoplasms, Connective Tissue / radiotherapy*
  • Neoplasms, Connective Tissue / surgery
  • Prosthesis-Related Infections / etiology*
  • Radiation Injuries / complications*
  • Radiotherapy, Adjuvant / adverse effects
  • Risk Factors
  • Sarcoma / radiotherapy*
  • Sarcoma / surgery
  • Treatment Outcome